Bortezomib induced the accumulation of proteasome target, hypoxia-inducible factor 1 alpha (HIF1a), and subsequent Vascular Endothelial Growth Factor A (VEGF A) synthesis in GBM cells [26]. The gene discussed is VEGFA; the disease is glioblastoma.